Minerva Medica 2021 February;112(1):114-7

DOI: 10.23736/S0026-4806.20.06727-0

language: English

Severe asthma at COVID-19 time: what is new on biologic therapies

Filippo PATRUCCO ^{1, 2} ✉, Elisa VILLA ³, Valentina FOCI ⁴, Alida BENFANTE ⁵, Michela BELLOCCHIA ⁶, Paolo SOLIDORO ^{6, 7}

¹ Division of Respiratory Diseases, Department of Medicine, Maggiore della Carità University Hospital, Novara, Italy; ² Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy; ³ Unit of Pneumology, A.S.L. Genova3, Villa Scassi Hospital, Genoa, Italy; ⁴ Unit U of Pneumology, Department of Medicine, A.S.L. Vercelli, Vercelli, Italy; ⁵ ProMISE Department, University of Palermo, Palermo, Italy; ⁶ Unit U of Pneumology, Department of Cardiovascular and Thoracic Medicine, Città della Salute e della Scienza, University of Turin, Turin, Italy; ⁷ Department of Medical Sciences, University of Turin, Turin, Italy

HTML PDF

top of page

YOUR ACCOUNT

YOUR ORDERS

SHOPPING BASKET

HOW TO ORDER

YOUR SUBSCRIPTIONS

YOUR ARTICLES

YOUR EBOOKS

COUPON

ACCESSIBILITY

Minerva Medica 2021 February;112(1):114-7

Severe asthma at COVID-19 time: what is new on biologic therapies

Publication History

Cite this article as

Corresponding author e-mail

Share